The U.S. Supreme Court has thrown out a case that sought to challenge the Food and Drug Administration’s expansion of the abortion pill mifepristone. In a 9 to 0 opinion, the highest court in the United States said that the doctors and medical groups challenging the FDA’s expansion of the drug lacked standing in the […]
![](https://thedcbeat.com/wp-content/uploads/CAMPAIGN-FINANCE-LAWS-6.jpg)